Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Non-muscle invasive bladder tumor"'
Autor:
A.D. Bouhnik, Jochen Walz, G. Gravis, Rajae Touzani, J. Campagna, Marc-Karim Bendiane, Géraldine Pignot, Patricia Marino
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2021, S1166-7087 (21), pp.00213-X. ⟨10.1016/j.purol.2021.08.035⟩
Progrès en Urologie, 2021, S1166-7087 (21), pp.00213-X. ⟨10.1016/j.purol.2021.08.035⟩
Progrès en Urologie, Elsevier Masson, 2021, S1166-7087 (21), pp.00213-X. ⟨10.1016/j.purol.2021.08.035⟩
Progrès en Urologie, 2021, S1166-7087 (21), pp.00213-X. ⟨10.1016/j.purol.2021.08.035⟩
Resume Introduction L’information transmise au diagnostic de Tumeur de vessie non infiltrant le muscle (TVNIM) est variable. Or, les patients bien informes sont plus impliques dans les decisions partagees. L’objectif de cette etude etait d’eval
Autor:
K. B. Lelyavin, V. V. Dvornichenko
Publikováno v:
Acta Biomedica Scientifica, Vol 0, Iss 5, Pp 53-59 (2013)
The article presents the analysis of the results of surgical treatment of 896 patients with muscle non-invasive bladder cancer who were operated in the period from 2000 to 2011: 662 (73,9 %) men and 234 (26,1 %) women of 31-84 years (average age - 61
Externí odkaz:
https://doaj.org/article/8ac2b42d7f5c48b29e486924f4c92f10
Autor:
Adnan Şimşir, Fuat Kizilay
Publikováno v:
Üroonkoloji Bülteni, Vol 18, Iss 2, Pp 40-45 (2019)
WOS: 000469807700001
Objective: Neutrophil-lymphocyte ratio (NLR) is a well-known, cost-effective biomarker of inflammatory conditions, and its protumor effect has been shown in different types of cancers. In this study, we aimed to evaluate the
Objective: Neutrophil-lymphocyte ratio (NLR) is a well-known, cost-effective biomarker of inflammatory conditions, and its protumor effect has been shown in different types of cancers. In this study, we aimed to evaluate the
Autor:
Onder Cinar, N. Aydin Mungan
Publikováno v:
Üroonkoloji Bülteni, Vol 18, Iss 1, Pp 30-33 (2019)
Bladder cancer (BC) is one of the commonly diagnosed urological cancers that causes human death, ranked as the seventh most common cancer worldwide. To date, no reliable diagnostic tool has been defined to recognize non-muscle invasive bladder tumors
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ahmed, Elabbady, Mohamed Mohieeldin, Hashad, Ahmed Fouad, Kotb, Dina Mohamed, Abdullah, Ahmad, Beltagy
Publikováno v:
International Journal of Health Sciences
Objective: The prognosis of bladder cancer patients with positive lymph node (LN) disease is affected by both the extent of lymphadenectomy and LN density retrieved during radical cystectomy. This study aimed at assessing the differences in LN metast
Autor:
Jianzhi Pang, Xiaofeng Yang, Fan Zhang, Jiehao Liu, Wei Wang, Junqian Luo, Yongping Cui, Sanhua Yan, Fang Luo, Xixi Su
Publikováno v:
Oncology Reports
Bladder cancer is common and widespread, and its incidence is increasing. Many new diagnostic methods combined with state-of-the-art technology have been intro- duced in cystoscopy to collect real-time images of the bladder mucosa for diagnosis, but
Autor:
Akagashi, Keigo, Nakajima, Hisao, Nitta, Toshikazu, Sato, Yoshikazu, Tobe, Musashi, Haga, Kazunori, Uchida, Kohsuke, Honma, Ichiya, Tanda, Hitoshi, Kato, Shuji, Ohnishi, Shigeki, Hanzawa, Tatsuo
Publikováno v:
泌尿器科紀要. 58(8):395-399
To determine the follow-up schedule in patients with non-muscle-invasive bladder cancer who had remained recurrence-free for 5 or more years, we retrospectively reviewed 258 patients with Ta and T1 bladder cancer who had been free of recurrence for a